Hsu C, Marx F, Guldenpfennig R, de Godoy M
Sci Rep. 2024; 14(1):31620.
PMID: 39738132
PMC: 11685506.
DOI: 10.1038/s41598-024-80176-w.
Fetse J, Olawode E, Deb S
Eur J Drug Metab Pharmacokinet. 2024; 49(6):661-676.
PMID: 39269556
DOI: 10.1007/s13318-024-00912-5.
Kang J, Li Y, Lee S, Yu K, Cho J
Clin Transl Sci. 2024; 17(5):e13834.
PMID: 38771175
PMC: 11107522.
DOI: 10.1111/cts.13834.
Puri S, Sahal D, Sharma U
Anal Sci Adv. 2024; 2(11-12):579-593.
PMID: 38715860
PMC: 10989556.
DOI: 10.1002/ansa.202100021.
Hall K, Tucker C, Dunn J, Webb T, Watts S, Kirkman E
J Clin Transl Sci. 2024; 8(1):e74.
PMID: 38715566
PMC: 11075112.
DOI: 10.1017/cts.2024.513.
Applications of chromatographic methods in metabolomics: A review.
Ovbude S, Sharmeen S, Kyei I, Olupathage H, Jones J, Bell R
J Chromatogr B Analyt Technol Biomed Life Sci. 2024; 1239:124124.
PMID: 38640794
PMC: 11618781.
DOI: 10.1016/j.jchromb.2024.124124.
Metabolic Signatures: Pioneering the Frontier of Rectal Cancer Diagnosis and Response to Neoadjuvant Treatment with Biomarkers-A Systematic Review.
Ciocan R, Ciocan A, Mihaileanu F, Ursu C, Ursu S, Bodea C
Int J Mol Sci. 2024; 25(4).
PMID: 38397058
PMC: 10889270.
DOI: 10.3390/ijms25042381.
VIBRANT: a phenotyping method for drug discovery using vibrational spectroscopy.
Nat Methods. 2024; 21(3):389-390.
PMID: 38374271
DOI: 10.1038/s41592-024-02186-w.
VIBRANT: spectral profiling for single-cell drug responses.
Liu X, Shi L, Zhao Z, Shu J, Min W
Nat Methods. 2024; 21(3):501-511.
PMID: 38374266
PMC: 11214684.
DOI: 10.1038/s41592-024-02185-x.
Developing a model to predict the early risk of hypertriglyceridemia based on inhibiting lipoprotein lipase (LPL): a translational study.
Hernandez-Baixauli J, Chomiciute G, Alcaide-Hidalgo J, Crescenti A, Baselga-Escudero L, Palacios-Jordan H
Sci Rep. 2023; 13(1):22646.
PMID: 38114521
PMC: 10730820.
DOI: 10.1038/s41598-023-49277-w.
Metabolomics: A useful tool for ischemic stroke research.
Li W, Shao C, Li C, Zhou H, Yu L, Yang J
J Pharm Anal. 2023; 13(9):968-983.
PMID: 37842657
PMC: 10568109.
DOI: 10.1016/j.jpha.2023.05.015.
Serum metabolomics of treatment response in myasthenia gravis.
Sikorski P, Li Y, Cheema M, Wolfe G, Kusner L, Aban I
PLoS One. 2023; 18(10):e0287654.
PMID: 37816000
PMC: 10564178.
DOI: 10.1371/journal.pone.0287654.
Absorption and Metabolism of Urolithin A and Ellagic Acid in Mice and Their Cytotoxicity in Human Colorectal Cancer Cells.
Lin I, Wu J, Fang C, Wang S, Liu Y, Ho S
Evid Based Complement Alternat Med. 2023; 2023:8264716.
PMID: 37706115
PMC: 10497365.
DOI: 10.1155/2023/8264716.
Plasma lipidomic analysis to investigate putative biomarkers of P-glycoprotein activity in healthy volunteers.
Decaix T, Magny R, Gouin-Thibaut I, Delavenne X, Mismetti P, Salem J
Clin Transl Sci. 2023; 16(10):1935-1946.
PMID: 37529981
PMC: 10582668.
DOI: 10.1111/cts.13601.
Metabolomics reveals the effects of hydroxysafflor yellow A on neurogenesis and axon regeneration after experimental traumatic brain injury.
Hu E, Li T, Li Z, Su H, Yan Q, Wang L
Pharm Biol. 2023; 61(1):1054-1064.
PMID: 37416997
PMC: 10332220.
DOI: 10.1080/13880209.2023.2229379.
Metabolomics of infectious diseases in the era of personalized medicine.
Rahman M, Schellhorn H
Front Mol Biosci. 2023; 10:1120376.
PMID: 37275959
PMC: 10233009.
DOI: 10.3389/fmolb.2023.1120376.
Multi-omics in Crohn's disease: New insights from inside.
Mu C, Zhao Q, Zhao Q, Yang L, Pang X, Liu T
Comput Struct Biotechnol J. 2023; 21:3054-3072.
PMID: 37273853
PMC: 10238466.
DOI: 10.1016/j.csbj.2023.05.010.
Metabolomic Profiling of Bipolar Disorder by H-NMR in Serbian Patients.
Simic K, Miladinovic Z, Todorovic N, Trifunovic S, Avramovic N, Gavrilovic A
Metabolites. 2023; 13(5).
PMID: 37233648
PMC: 10223505.
DOI: 10.3390/metabo13050607.
Combined Metabolome and Transcriptome Analysis Elucidates Sugar Accumulation in Wucai ( L.).
Wang C, Zhou J, Zhang S, Gao X, Yang Y, Hou J
Int J Mol Sci. 2023; 24(5).
PMID: 36902245
PMC: 10003340.
DOI: 10.3390/ijms24054816.
When cancer drug resistance meets metabolomics (bulk, single-cell and/or spatial): Progress, potential, and perspective.
Zhang Z, Bao C, Jiang L, Wang S, Wang K, Lu C
Front Oncol. 2023; 12:1054233.
PMID: 36686803
PMC: 9854130.
DOI: 10.3389/fonc.2022.1054233.